High dose statins should be used in all patients undergoing percutaneous coronary intervention

International Journal of Cardiology

Volumn 172, Issue 1, 2014, Pages

  Sardella, Gennaro ^a   Lucisano, Luigi ^a  

^a POLICLINICO UMBERTO I   (Italy)

Author keywords

Elective coronary angioplasty; Periprocedural MI; Statin reload

Indexed keywords

ATORVASTATIN; CREATINE KINASE MB; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ROSUVASTATIN; TROPONIN T;

CARDIOVASCULAR RISK; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG MEGADOSE; HEART INFARCTION; HUMAN; LETTER; LOADING DRUG DOSE; LONG TERM CARE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RISK REDUCTION; TREATMENT INDICATION; UPREGULATION;

ELECTIVE CORONARY ANGIOPLASTY; PERIPROCEDURAL MI; STATIN RELOAD;

ANGINA PECTORIS; ANGIOPLASTY, BALLOON, CORONARY; FEMALE; FLUOROBENZENES; HUMANS; INTRAOPERATIVE COMPLICATIONS; MALE; MYOCARDIAL INFARCTION; PYRIMIDINES; SULFONAMIDES;

EID: 84894053931     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.12.107     Document Type: Article

References (3)

1. G. Sardella, G. Conti, and M. Donahue et al. Rosuvastatin pretreatment in patients undergoing elective PCI to reduce the incidence of myocardial periprocedural necrosis: the ROMA trial Catheter Cardiovasc Interv 81 1 Jan 1 2013 E36 E43
2. G. Sardella, L. Lucisano, and M. Mancone et al. Comparison of high reloading ROsuvastatin and Atorvastatin pretreatment in patients undergoing elective PCI to reduce the incidence of MyocArdial periprocedural necrosis. The ROMA II trial Int J Cardiol 168 4 Jul 11 2013 3715 3720
3. S. Cay, G. Cagirci, N. Sen, Y. Balbay, T. Durmaz, and S. Aydogdu Prevention of peri-procedural myocardial injury using a single high loading dose of Rosuvastatin Cardiovasc Drugs Ther 24 1 Feb 2010 41 47